You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 164 No. 20, November 8, 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Venous Thromboembolism
 •Cardiovascular System
 •Adverse Effects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Establishing an Optimal Therapeutic Range for Coumarins

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In their article recently published in the ARCHIVES, Torn and colleagues1 underscore the importance to establish an optimal therapeutic range for people taking warfarin. Warfarin, in fact, is associated with a high risk of bleeding when the international normalized ratio rises above the upper limits and with a lacking prophylactic effect when it falls under the lower limits of the therapeutic range. To encompass these problems, a strict control performed by experienced personnel in anticoagulant (AC) clinics and the use of computer-assisted dosage adjustment are recommended in the editorial by O’Donnel and Hirsh2 in the same ARCHIVES issue.

Although we do not disagree with this position, we believe that the collective relevance of a service is based on much more than a mere technologic intervention. It is known that elderly people currently do not receive adequate AC prophylaxis, although they are at high risk of thromboembolic events.2 . . . [Full Text of this Article]


AUTHOR INFORMATION
Giuseppe Bellelli, MD; Renzo Rozzini, MD; Marco Trabucchi, MD



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Lowering the Intensity of Oral Anticoagulant Therapy: Effects on the Risk of Hemorrhage and Thromboembolism
Marieke Torn, Felix J. M. van der Meer, and Frits R. Rosendaal
Arch Intern Med. 2004;164(6):668-673.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.